These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7600545)

  • 1. The quantitation of altered hepatic foci during multistage hepatocarcinogenesis in the rat: transforming growth factor alpha expression as a marker for the stage of progression.
    Dragan Y; Teeguarden J; Campbell H; Hsia S; Pitot H
    Cancer Lett; 1995 Jun; 93(1):73-83. PubMed ID: 7600545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-alpha in carcinogen-induced F344 rat hepatic foci.
    Steinmetz KL; Klaunig JE
    Toxicol Appl Pharmacol; 1996 Sep; 140(1):131-45. PubMed ID: 8806879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of experimental and theoretical parameters of the Moolgavkar-Venzon-Knudson incidence function for the stages of initiation and promotion in rat hepatocarcinogenesis.
    Dragan YP; Hully J; Baker K; Crow R; Mass MJ; Pitot HC
    Toxicology; 1995 Sep; 102(1-2):161-75. PubMed ID: 7482551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat.
    Sargent L; Dragan Y; Xu YH; Sattler G; Wiley J; Pitot HC
    Cancer Res; 1996 Jul; 56(13):2985-91. PubMed ID: 8674052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
    Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
    Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular distributions of molecules with altered expression specific to the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model.
    Takahashi M; Shibutani M; Woo GH; Inoue K; Fujimoto H; Igarashi K; Kanno J; Hirose M; Nishikawa A
    Carcinogenesis; 2008 Nov; 29(11):2218-26. PubMed ID: 18586688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
    DiGiovanni J; Rho O; Xian W; Beltràn L
    Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.
    Gotzmann J; Fischer AN; Zojer M; Mikula M; Proell V; Huber H; Jechlinger M; Waerner T; Weith A; Beug H; Mikulits W
    Oncogene; 2006 May; 25(22):3170-85. PubMed ID: 16607286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.
    Paik SY; Park YN; Kim H; Park C
    Mod Pathol; 2003 Jan; 16(1):86-96. PubMed ID: 12527718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-alpha expression is altered during experimental hepatocarcinogenesis.
    Burr AW; Toole K; Mathew J; Hines JE; Chapman C; Burt AD
    J Pathol; 1996 Jul; 179(3):276-82. PubMed ID: 8774483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the antioxidant defense and hepatic drug metabolizing enzyme and isoenzyme levels, 8-hydroxydeoxyguanosine formation and expressions of c-raf.1 and insulin-like growth factor II genes during the stages of development of hepatocellular carcinoma in rats.
    Mukherjee B; Das T; Ghosh S; Datta S
    Eur J Cancer Prev; 2007 Aug; 16(4):363-71. PubMed ID: 17554210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
    Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-alpha expression in rat experimental hepatocarcinogenesis.
    Pérez-Tomás R; Mayol X; Culleré X; Díaz Ruiz C; Domingo J
    Histol Histopathol; 1992 Jul; 7(3):457-62. PubMed ID: 1504466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of multistage carcinogenesis in rat liver.
    Pitot HC; Dragan YP; Teeguarden J; Hsia S; Campbell H
    Toxicol Pathol; 1996; 24(1):119-28. PubMed ID: 8839289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
    Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-parenchymal liver cells support the growth advantage in the first stages of hepatocarcinogenesis.
    Drucker C; Parzefall W; Teufelhofer O; Grusch M; Ellinger A; Schulte-Hermann R; Grasl-Kraupp B
    Carcinogenesis; 2006 Jan; 27(1):152-61. PubMed ID: 16081514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: potential roles of early DNA damage and liver metallothionein expression.
    Chakraborty T; Chatterjee A; Rana A; Srivastawa S; Damodaran S; Chatterjee M
    Life Sci; 2007 Jul; 81(6):489-99. PubMed ID: 17651763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.